Figures & data
Table 1. The characteristics of the included studies.
Table 2. Intervention and outcome measures of the included studies.
Figure 4. Meta-analysis of the bilirubin levels of Yingzhihuang oral liquid group and the control group during treating neonatal jaundice on third day.
![Figure 4. Meta-analysis of the bilirubin levels of Yingzhihuang oral liquid group and the control group during treating neonatal jaundice on third day.](/cms/asset/164a7d38-f288-45c0-bd5c-c6edbfc2ee02/iphb_a_1262432_f0004_c.jpg)
Figure 5. Meta-analysis of the bilirubin levels of Yingzhihuang oral liquid group and the control group during treating neonatal jaundice on fifth day.
![Figure 5. Meta-analysis of the bilirubin levels of Yingzhihuang oral liquid group and the control group during treating neonatal jaundice on fifth day.](/cms/asset/206529d5-68f3-4291-889b-de26532eca47/iphb_a_1262432_f0005_c.jpg)
Figure 6. Meta-analysis of the subsiding time of jaundice of Yingzhihuang oral liquid and the control group.
![Figure 6. Meta-analysis of the subsiding time of jaundice of Yingzhihuang oral liquid and the control group.](/cms/asset/5f4d1490-d4a6-44c7-8794-6bfd656ef8aa/iphb_a_1262432_f0006_c.jpg)